CorMedix (CRMD) Current Assets (2010 - 2026)

CorMedix has reported Current Assets for 15 years, with the latest figure at $367.1 million in Q4 2025.

• Quarterly Current Assets rose 220.36% year-over-year to $367.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $367.1 million (up 220.36% YoY) and the FY2025 annual result came in at $367.1 million, up 220.36% from the prior year.
• Current Assets climbed to $367.1 million in Q4 2025 per CRMD's latest filing, from $259.5 million in the prior quarter.
• Over five years, Current Assets peaked at $367.1 million in Q4 2025 and troughed at $53.2 million in Q2 2024.
• A 5-year average of $107.7 million and a median of $73.1 million in 2021 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2025: Current Assets declined 24.75% in 2022, then surged 366.32% in 2025.
• Over 5 years, Current Assets stood at $66.5 million in 2021, then declined by 10.41% to $59.6 million in 2022, then soared by 33.42% to $79.5 million in 2023, then surged by 44.21% to $114.6 million in 2024, then jumped by 220.36% to $367.1 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $367.1 million, $259.5 million, and $248.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.